New Drug Launches See 4-Year Lag in India vs US and EU: Lobby of Foreign Drugmakers to DCGI
Launching new drugs in India takes up to a four-year delay compared to the US or the European Union, primarily due to complex clinical trial regulations, the lobby of foreign drugmakers told India’s apex drug regulator, News18 has learnt.
Source: news18.com